期刊文献+

2型糖尿病下肢动脉病变介入治疗对缺血动脉内血管性血友病因子、纤维蛋白原的影响及其意义 被引量:7

Effects of von Willebrand factor and fibrinogen of lower extremity artery in patients with type 2 diabetic lower extremity arterial diseases by percutaneous lower extremity arterial intervention
下载PDF
导出
摘要 目的观察2型糖尿病合并下肢动脉病变患者介入治疗对下肢动脉内血管性血友病因子(vonWillebrand factor,vWF)、血浆纤维蛋白原(fibrinogen,Fb)的影响。方法选择2型糖尿病合并下肢动脉病变(Fontaine分级Ⅱb~Ⅳ级)患者66例,术前常规检查并取静脉血检测vWF、Fb水平。行介入手术时于动脉鞘植入成功后动脉鞘内、介入前缺血部位动脉血和介入后病变动脉以远段、介入前和术后1天、2天、7天、14天分别取静脉血检测vWF、Fb水平。观察内皮功能、凝血指标的变化,同时观察其他临床指标。结果介入组介入前动脉鞘内、介入前缺血部位动脉和介入后病变动脉以远段的vWF、Fb水平逐渐升高;vWF(147.6±17.3)%、(231.3±32.6)%、(299.2±35.2)%,Fb(3.91±0.26)g/L、(4.97±0.29)g/L、(5.69±0.28)g/L(均P<0.01);静脉血vWF、Fb水平于术后1天达高峰,术后7天恢复至术前水平,术后14天vWF、Fb水平低于治疗前。静脉血介入前、介入1天、2天、7天、14天vWF(148.3±16.4)%、(199.3±18.6)%、(176.5±18.1)%、(144.1±15.3)%、(128.5±11.4)%、Fib(3.88±0.23)g/L、(4.96±0.30)g/L、(4.59±0.25)g/L、(3.96±0.32)g/L、(3.11±0.19)g/L(均P<0.01)。结论缺血可引起内皮功能的损伤和凝血指标的变化,介入治疗可进一步增加动脉内皮功能的损伤和高凝状态,应早期进行内皮功能保护和抗凝治疗,介入后下肢血流改善,动脉内膜修复后,其内皮功能改善,高凝状态缓解。 Objective To observe the effects of von Willebrand factor(vWF) and fibrinogen(Fb) of lower extremity artery in patients with type 2 diabetic lower extremity artery disease by percutaneous lower extremity arteries intervention. Methods Sixty-six type 2 diabetes patients with lower extremity arterial diseases (Fontaine degree ]] b- I~) were examined routinely and their levels of vWF and Fb were tested. In percutaneous lower extremity arteries intervention, the arterial blood specimens were collected after the arterial sheath placement completed by arterial sheath successfully, after the catheter guide wire passed through the arterial segment of stenosis or occlusion by distal artery of stenosis or occlusion site, after balloon dilatation or stent implantation by distal artery of stenosis or occlusion site, respectively. The vein blood specimens were collected before interventional operation and one day, two days, seven days, fourteen days after interventional operation,respectively. The vein blood specimens were collected before interventional operation and 24 hours, 48 hours, 1 week,2 weeks after interventional operation, respectively. Levels of vWF and Fb were tested with all artery and vein blood specimens. The changes of endothelial function, blood coagulation index and other clinical indexes at the same time were observed. Results Blood specimens of arterial sheath and diseased arteries distal segment artery ( ischemia in artery) before interventional therapy, blood specimens of diseased arteries distal segment artery after interventional therapy, the levels of vWF were ( 147.6 ±17.3) %, ( 231.3 ± 32.6 )%, ( 299.2 ±35. 2)%,the levels of Fb were (3.91±0.26) g/L,(4.97±0.29) g/L,(5.69±0.28) g/L. So,levels of vWF,Fb in diseased artery distal segment artery ( isehemia artery ) were significantly increased before interventional therapy( P G 0.01) ,and the indexes further increased after interventional therapy( P 〈0.01). Before interventional therapy and one day, two days, seven days, fourteen days after interventional therapy, the vein blood levels of vWF, Fb were (148.3± 16.4)%,(3.88±0.23) g/L,(199.3±18.6)%,(4.96±0.30) g/L,(176.5±18.1)%,(4.59±0.25) g/L,(144.1± 15.3) %,(3.96±0.32) g/L,(144.1±15.3)%,(3.96±0.32) g/L. So,the vein blood levels of vWF,Fb reached peaks in 24 hours after interventional therapy ( P〈0.01), dropped to the level before interventional therapy at 1 week and the levels were lower at 2 weeks compared with those before interventional therapy. Conclusion Isehemia can induce endothelial function injury and hypercoagulable states, interventional therapy can further increase arterial endothelial function injury and hypercoagulable states, early protection of endothelial function and anticoagulant therapy are necessary after interventional therapy, because of improvement of blood flow of lower extremity after interventional therapy. When arterial endomembrane is repaired,its endothelial function will be improved and hypercoagulable states will be eased.
出处 《临床荟萃》 CAS 2013年第2期158-161,共4页 Clinical Focus
关键词 糖尿病 2型 糖尿病并发症 下肢 von WILLEBRAND因子 纤维蛋白原 diabetes mellitus, type 2 diabetes complications lower extremity yon willehrand factor fibrinogen
  • 相关文献

参考文献10

  • 1王富军,王原,杨艳辉,杜亚萍,齐惠卿,孙寿广,代红沙.2型糖尿病下肢血管病变介入治疗临床疗效分析[J].临床荟萃,2008,23(19):1377-1379. 被引量:13
  • 2Park CS,Ihm SH,Yoo KD. Relation between C-reactive protein,homocysteine levels,fibrinogen,and lipoprotein levels and leukocyte and platelet counts,and 10-year risk for cardiovascular disease among healthy adults in the USA[J].American Journal of Cardiology,2010,(09):1284-1288.
  • 3王富军,赵允,丁海霞,齐会卿,杨艳辉,杜亚萍.2型糖尿病下肢血管病变患者介入治疗前后血管性血友病因子、纤维蛋白变化及其意义[J].临床荟萃,2011,26(1):64-65. 被引量:3
  • 4Frankel DS,Meigs JB,Massaro JM. von Willebrand factor,type 2 diabetes mellitus,and risk of cardiovascular disease:the Framingham Offspring Study[J].Circulation,2008,(24):2533-2539.doi:10.1161/CIRCULATIONAHA.108.792986.
  • 5Riccioni G,D' Orazio N,Palumbo N. Relationship between plasma antioxidant concentrations and carotid intimamedia thickness:the Asymptomatic Carotid Atherosclerotic Disease In Manfredonia Study[J].European Journal of Cardiovascular Prevention and Rehabilitation,2009,(03):351-357.
  • 6Wakabayashi I,Masuda H. Association of acute-phase reactants with arterial stiffness in patients with type 2 diabetes mellitus[J].Clinica Chimica Acta,2006,(1/2):230-235.
  • 7Vigilance JE,Reid HL. Segmental blood flow and rheological determinants in diabetic patients with peripheral occlusive arterial disease[J].Journal of Diabetes and its Complications,2008,(03):210-216.doi:10.1016/j.jdiacomp.2006.11.001.
  • 8李媛媛,来庆友,商德亚,刘东兴.急性心肌梗死急诊介入治疗中替罗非班对冠状动脉内皮细胞功能的影响[J].山东大学学报(医学版),2008,46(5):494-497. 被引量:10
  • 9Siablis D,Karnabatidis D,Katsanos K. Infrapopliteal application of sirolimus-eluting versus bare metal stents for critical limb ischemia:analysis of long-term angiographic and clinical outcome[J].Journal of Vascular and Interventional Radiology,2009,(09):1141-1150.doi:10.1016/j.jvir.2009.05.031.
  • 10Zeller T,Frank U,Burgelin K. Initial clinical experience with percutaneous atherectomy in the infragenicular arteries[J].Journal of Endovascular Therapy,2003,(05):987-993.

二级参考文献24

  • 1路亚枫,胡大一,翟艳苓.急性心肌梗死患者直接PCI前后血浆TF、TFPI水平的变化及其临床意义[J].首都医科大学学报,2005,26(4):457-459. 被引量:5
  • 2刘瑛,郭力.纤维蛋白原水平与颈动脉粥样硬化[J].医学综述,2006,12(7):441-443. 被引量:7
  • 3陈海燕,李明龙,李茵茵.2型糖尿病患者血纤维蛋白原与下肢血管病变的关系[J].临床内科杂志,2007,24(3):171-173. 被引量:10
  • 4庄百溪,马鲁波,于春利,张童,杨淼,石波,史大卓.糖尿病下肢血管病变介入治疗初步探讨[J].中华医学杂志,2007,87(26):1821-1824. 被引量:26
  • 5Doweik L, Maca T, Schillinger M, et al. Fibrinogen predict mortality in high risk patients with peripheral artery disease[J]. Eur J Vasc Endovasc Surg,2003,26(4):381-386.
  • 6Rudofsky G,StrubeI G, Michler E, et al. Influence of fibrinogen and hematocrit on the early outcome of angioplasty in patients with PAOD[J]. J Endovasc Ther,2004,11(2) :125-131.
  • 7Channon K. Oxidative stress and coronary plaque stability[J]. Arterioscler Thromb Vasc Biol, 2002, 22(11 ) : 1751-1752.
  • 8Elmouchi D A, Bates E R. Platelet glycoprotein Ⅱb/Ⅲa inhibitor therapy in st-segment elevation acute coronary syndromes [J]. Mineva Cardioangiol, 2003, 51(5):547-560.
  • 9Ito H, Taniyama Y, Iwakura K, et al. Intravenous nicorandil can preserve microvascular integrity and myocardial viability in patients with reperfused anterior wall myocardial infarction[J].J Am Coll Cardiol, 1999, 33(3) :654-660.
  • 10Heitzer T, Schlinzig T, Krohn K, et al. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease[J]. Circulation, 2001, 104(22):2673-2678.

共引文献21

同被引文献68

  • 1李丽辉.综合护理干预对老年糖尿病足患者的影响[J].当代护士(下旬刊),2010,17(9):18-19. 被引量:10
  • 2李洁,赵明,王燕燕.糖尿病足的分子生物学机制[J].中国临床康复,2006,10(12):142-144. 被引量:7
  • 3许樟荣.糖尿病足病的流行病学及诊治现状[J].内科理论与实践,2007,2(3):150-152. 被引量:34
  • 4Triant VA, Meigs JB, Grinspoon SK. Association of C-reactive protein and HIV infection with acute myocardial infarction [J]. J Acquir Immune Defic Syndr, 2009,51 (3) : 268-273.
  • 5Heart Protection Study Collaborative Group,Emberson J, Bennett D,et al. C-reactive protein concentration and the vascular benefits ofstatin therapy :an analysis of 20,536 pa- tients in the Heart ProtectionStudy [J]. Lancet,2011,377 (9764) : 469-476.
  • 6Pereira RR, Amladi ST,Varthakavi PK. A study of the preva- lence ofdiabetes,insulin resistance,lipid abnormalities,and cardiovascularrisk factors in patients with chronic plaque pso- riasis [J]. Indian J Demlatol, 2011,56(5 ) : 520-526.
  • 7Hiro T,Kimura T,Morimoto T,et al. Diabetes mellitus is a major negative determinant of coronary plaque regression dur- ing statin therapy in patients with acute coronary syndrome- serial intravascular ultrasound observations from the Japan Assessment of Pitavastatin and Atorvastatin in Acute Coro- nary Syndrome Trial (the JAPAN-ACS Trial) [J]. Circ J, 2010,74(6) : 1165-1174.
  • 8Akazawa S,Tojikubo M,Nakano Y,et al. Usefulness of sum of thethickness of plaque in the carotid artery for predicting the presenceand the extent of the coronary artery disease in patients with type 2 diabetes mellitus without known coro- nary artery disease [J]. DiabetesRes Clin Pract,2012,96(2) : 111-118.
  • 9Nozue T,Yamamoto S ,Tohyama S ,et al. Impact of diabetes mellituson coronary atherosclerosis and plaque composition under statintherapy-subanalysis of the TRUTH study [J]. Circ J,2012,76(9) : 134-136.
  • 10王富军,杜亚萍,杨艳辉,葛丽娜,刘月芹,高丽霞,谷涌泉.自体外周血干细胞移植治疗糖尿病足11例临床研究[J].临床荟萃,2007,22(23):1729-1730. 被引量:15

引证文献7

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部